SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics ($MLTX) is trending after a significant drop following mixed results from phase 3 trials, leading to community debate about the severity of the market's reaction. Some investors believe the sell-off is an overreaction, given the company's cash reserves and pipeline, while others cite concerns about commercial viability and existing market competition. Discussions include potential buyout scenarios and the possibility of a short squeeze.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a "culture coin," with the community emphasizing freedom and growth. Discussions revolve around its utility compared to traditional cannabis companies, and where to purchase it. Some users are also discussing potential connections to broader cannabis legalization efforts.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending due to a sharp decline in share price following a controversial, now-retracted, LinkedIn post by a former FDA official questioning the safety and efficacy of their drug, Lupkynis. The community is actively debating the motivations behind the post, potential market manipulation, and the need for a strong response from the company, with some even calling for legal action. Broader discussions include speculation about a potential buyout and frustration with the company's leadership.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending as investors debate whether its recent dip represents a buying opportunity or signals deeper issues, especially in comparison to competitors like Chipotle. The community is actively discussing the impact of the COO's departure and weighing the company's expansion plans against concerns about consumer spending and valuation. Some are optimistic about a potential rebound, citing strong fundamentals and growth potential, while others express caution and suggest further downside.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

APDN is trending due to a recently announced private placement of up to $58 million to initiate a BNB-focused digital asset strategy, with plans to change its ticker symbol to BNBX. The community is actively discussing the potential for this move into crypto to mirror the success of similar plays, while also expressing concerns about potential dilution and past losses. Some traders are optimistic about a potential surge, drawing comparisons to other low-float stocks with treasury news.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its constructive chart structure, resilient price action, and steady accumulation. Buyers appear confident, with support zones being respected and demand visible in the order book, signaling a potential breakout. Recent mentions of UpDog are also contributing to the increased attention.

American Exceptionalism Acquisition Corp. A is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on July 11, 2025 and is headquartered in Menlo Park, CA.

American Exceptionalism Acquisition Corp. A - Ordinary Shares - Class A

American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp. A ($AEXA) is trending as the Chamath Palihapitiya-backed SPAC seeks a merger, with speculation focusing on potential targets like Starlink or Discord. The community is expressing both excitement and skepticism, reminiscent of the earlier SPAC boom, while awaiting further news and potential option availability. Bullish sentiment is countered by concerns about the stock's valuation and potential downsides.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar ($SATS) is trending amid reports that Verizon is in talks to acquire its wireless spectrum, potentially driving the price over $90. The community is buzzing about a possible short squeeze due to the stock being undervalued and the potential for FCC approval of pending deals. Bullish sentiment is further fueled by speculation of net cash per share reaching $84 after deal completions.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is trending due to speculation around low float runners and potential multi-day momentum. The stock's previous performance, coupled with interest in Chinese low-float plays, has fueled community discussions about possible squeezes and high price targets. Some traders are also wary of potential rug pulls or offerings.

AKIRA LABS

AKIRA.X is trending as the community discusses potential integration or collaboration with SOL.X and WAGMI.X. Many traders are adding AKIRA.X to their watchlists, anticipating potential green candles and inclusion in the current meme cycle. The community seems to be bullish on AKIRA.X, with some highlighting it as a gem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Warner Bros. Discovery stock falls after Advance/Newhouse sells $1B stake

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) stock declined 4.9% Tuesday, falling from $11.46 to $10.90 after major shareholder Advance/Newhouse sold over $1 billion in shares.

Warner Bros. Discovery to split into two media companies

Investing.com -- Warner Bros. Discovery (NASDAQ: NASDAQ:WBD) shares paused trading on Monday pending a significant announcement. The company revealed plans to separate into two leading media corporations.

BT set to sell TNT Sports stake to Warner Bros Discovery – FT

Warner Bros, Arm and Peloton fall premarket;  Tapestry, Kenvue rise

Investing.com -- U.S. stock futures rose strongly Thursday on hopes that a trade deal between the U.S. and the U.K., as well as talks could reduce uncertainty surrounding global trade policies. 

MoffettNathanson sees more downside risk for media and internet stocks

Investing.com -- A sudden shift in U.S. trade policy has sharply darkened the economic outlook, with MoffettNathanson now warning that sweeping new tariffs could push the country into recession and erase $45 billion in expected ad spending in 2025. Though Trump said authorized a 90-day pause on "reciprocal" and 10% tariffs, effective immediately.

Deutsche Bank downgrades Paramount Global, cuts target on dour outlook

Investing.com -- Deutsche Bank downgraded Paramount Global to "Hold" from "Buy" on Tuesday, citing lower earnings expectations and rising risks to the advertising outlook, while also reducing its price target to $12 from $15.

Warner Bros jumps on streaming profits guide, encouraging studios, D2C results

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) said on Thursday it expects its streaming profits to double in 2025 and is projecting at least 150 million subscribers by 2026.

Warner Bros. Discovery misses top and bottom line estimates in Q4

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) reported fourth-quarter earnings and revenue that fell short of analyst expectations.

MoffettNathanson upgrades Warner Bros Discovery, downgrades Fox Corp

Investing.com -- MoffettNathanson upgraded Warner Bros Discovery Inc (NASDAQ:WBD) to "Buy" from "Neutral," citing improved financial stability, growth at Max, and easing studio challenges.

Will M&A really be a way out for media companies in 2025?

Investing.com -- While there are expectations of mergers and acquisitions (M&A) in the U.S. media industry in 2025,  Barclays  (LON:BARC) analysts suggest that only a few strategic transactions may truly make sense. 

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros.Discovery Inc - Ordinary Shares - Class B

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

DISCB
Discovery Communications, Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest DISCB News

DISCB Discovery Communications, Inc